Manuel Rodríguez Lopez, Jr., MD

Hematologist
Hospital Universitario Alvaro Cunqueiro, EOXI Vigo
Vigo, Galicia, Spain

Graduated in Medicine and Surgery by Facultad de Medicina de Santiago de Compostela (Galiza- Spain)
MD in Haematology and Hemotherapie by Instituto Portugues de Oncologia de Oporto (Portugal)
Master in Thrombotic Pathology by Universidad de Navarra (Spain)
Master in Congenital and Acquired Coagulopathies by Universidad de Alcala (Spain)
Miember of Scientific Comission of Real Fundacion Victoria Eugenia (Spain)

Presentation(s):

• PB0250 - Exploring clinical profile and patient-reported outcomes of people with non-inhibitor severe hemophilia A: insights from the Spanish cohort of ‘Cost Haemophilia: Socioeconomic Survey’ (CHESS)

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0543 - "Experience of switching to EHL-CFVIII or non-replacement therapies in patients with severe or moderate hemophilia a without inhibitor from the galician community: retrospective analysis"

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0526 - Current challenges in management and implementation of Hemophilia Gene Therapy (HGT) in Spain and Portugal: a survey-based study

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PO12 - Observational study to describe the clinical impact of treatment patterns in people with mild to moderate hemophilia A in Spain - Lemon Study.

  Wednesday, June 26, 2024
  13:00 – 14:00 ICT